Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.

Zhen LinYi-Zhao XieMing-Chun ZhaoPin-Pin HouJuan TangGuang-Liang Chen

Published in: Cancer cell international (2021)

These findings suggest that XDH is a valuable prognostic biomarker in HCC and other cancers and indicate that it may function in tumor immunology. Loss of XDH expression may be an immune evasion mechanism for HCC.

Keyphrases

poor prognosis
uric acid